Design and fabrication of salicylic acid-based polyanhydride devices for wound healing and tissue regeneration
Citation & Export
Hide
Simple citation
Snyder, Sabrina Sachiko.
Design and fabrication of salicylic acid-based polyanhydride devices for wound healing and tissue regeneration. Retrieved from
https://doi.org/doi:10.7282/T3319TFJ
Export
Description
TitleDesign and fabrication of salicylic acid-based polyanhydride devices for wound healing and tissue regeneration
Date Created2013
Other Date2013-05 (degree)
Extentxxiii, 151 p. : ill.
DescriptionWound healing and tissue regeneration after injury is regulated by inflammatory response degree and duration. Localized, controlled release of anti-inflammatory drugs at the injury site can modulate inflammation, thereby, controlling the wound healing process. This research uses salicylic acid-based poly(anhydride-esters) (SAPAEs) to release salicylic acid (SA), an anti-inflammatory drug, in a controlled manner for wound healing and tissue regeneration applications. In the first studies, SAPAE-containing bone regeneration devices were developed. SAPAEs were melt-cast as guided bone regeneration (GBR) caps onto osteoconductive scaffolds, then in vitro drug release was quantified. In vivo inflammation and bone regeneration capacity were evaluated. The SAPAE caps suppressed inflammation and had no effect on bone formation in a rabbit cranial trephine defect model. Second, SAPAEs were blended with polycaprolactone (PCL) and electrospun to create flexible GBR mats. Electrospun mat structure, mechanical properties, and in vitro drug release were determined. Mats were assessed in vivo for their ability to prevent heterotopic ossification (HO) in a rat femoral defect model. Initial studies indicate that the SAPAE:PCL blends prevent HO, but also inhibit bone regeneration in the defect site. Third, SAPAE:poly(ethylene glycol) (PEG) copolymers at various ratios were developed for fibrous adhesion prevention. These, copolymers behave as viscous liquids at room temperature. Rheological properties, in vitro drug release profiles, cytotoxicity, and anti-inflammatory activity were assessed. Shear viscosities are comparable with FDA-approved fibrous adhesion barriers and have the additional benefit of drug release to modulate the excessive inflammation that causes adhesion formation. Fourthly, SAPAEs exhibit an initial lag period in drug release, which could be unfavorable in applications where immediate SA release is desired. By varying the amounts of small molecules incorporated into an SAPAE matrix with an 11-day lag period, immediate and constant SA release profiles were achieved. Overall, SAPAEs were utilized to create bone scaffolds and wraps to direct bone growth, as injectable adhesion barrier devices, and to control early SA release. All these approaches were focused on controlling the wound healing process with biodegradable SAPAEs.
NotePh.D.
NoteIncludes bibliographical references
Noteby Sabrina Sachiko Snyder
Genretheses, ETD doctoral
Languageeng
CollectionGraduate School - New Brunswick Electronic Theses and Dissertations
Organization NameRutgers, The State University of New Jersey
RightsThe author owns the copyright to this work.